Spruce Biosciences (SPRB) Earnings Date & Reports

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SPRB is expected to report earnings to fall 12.28% to -586 cents per share on November 16

Spruce Biosciences SPRB Stock Earnings Reports

Q3'26

Est.

$-5.86

Q2'26

Missed

by $5.83

Q1'26

Missed

by $8.29

Q4'25

Missed

by $11.14

Q3'25

Missed

by $14.36

The last earnings report on August 12 showed earnings per share of -667 cents, missing the estimate of -85 cents. With 26.16K shares outstanding, the current market capitalization sits at 136.54M.

View a ticker or compare two or three

SPRB

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for SPRB